Dr. Sedat Ofluoğlu is a nuclear medicine specialist and flight surgeon at Biruni University Hospital, where he also serves as President of the Aviation Medical Center (AeMC). His practice bridges two fields: diagnostic and therapeutic nuclear medicine on one side, and aviation and aerospace medicine on the other, including fitness-for-duty examinations for flight crew.
He graduated from Akdeniz University Faculty of Medicine in 1992. Between 1997 and 2002 he completed his specialist training in nuclear medicine at the University of Vienna, with his qualification recognised through the equivalency process at Istanbul University Cerrahpaşa Faculty of Medicine in 2002. In 2005 he obtained his Aviation Medicine Certificate through DGCA training at Eskişehir Air Hospital.
Dr. Ofluoğlu began his career as a general practitioner at Mezraa Health Center and Private Vatan Hospital between 1992 and 1997, before moving to Vienna as a resident physician in the Department of Nuclear Medicine. Since 2002 he has worked as a nuclear medicine specialist at German Hospital, Italian Hospital, GOP Taksim Training and Research Hospital, Medical Park Florya, Liv Hospital Bahçeşehir and Istanbul Oncology Hospital. He has practised as a flight surgeon since 2005, at German Hospital, Private Family Hospital and Biruni University Hospital, and has led the Aviation Medical Center since 2018.
His clinical interests cover nuclear medicine diagnosis and treatment methods, conventional nuclear medicine and PET-CT imaging, thyroid diseases including examination, biopsy and treatment, aerospace medicine, and aviation fitness-for-duty inspections.
Dr. Ofluoğlu has published extensively in international peer-reviewed journals, with research spanning receptor scintigraphy and novel radiopharmaceuticals, radionuclide therapy, radiation synovectomy, patient radiation dosimetry, myocardial perfusion PET and thyroid disease. His work has appeared in journals including the Journal of Nuclear Medicine, Nuklearmedizin, Thyroid and the Journal of the American College of Surgeons. He is a member of the Turkish Nuclear Medicine Association, the European Society of Nuclear Medicine, the Aviation Medicine Association and the Aerospace Medicine Platform.
Education
-
Doctor of Medicine
Akdeniz University, Faculty of Medicine
1985-1992
-
Nuclear Medicine (residency)
University of Vienna; Istanbul University Cerrahpaşa Faculty of Medicine (equivalency)
1997-2002
-
Aviation Medicine Certificate
DGCA Training, Eskişehir Air Hospital
2005
Academic & Administrative Roles
-
General Practitioner
Mezraa Health Center; Private Vatan Hospital
1992-1997
-
Assistant Physician
University of Vienna, Department of Nuclear Medicine
1997-2002
-
Assistant Physician (equivalency)
Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine
2002
-
Nuclear Medicine Specialist
German Hospital, Italian Hospital, GOP Taksim Training and Research Hospital, Medical Park Florya, Liv Hospital Bahçeşehir, Istanbul Oncology Hospital
2002-present
-
Flight Surgeon
German Hospital, Private Family Hospital, Biruni University Hospital
2005-present
-
Aviation Medical Center (AeMC) President
2018-present
- Turkish Nuclear Medicine Association
- European Society of Nuclear Medicine
- Aviation Medicine Association
- Aerospace Medicine Platform
-
Radiation exposure around patients after administration of 123I-metaiodobenzylguanidine (MIBG)
Nuklearmedizin · 2002 -
Radiation synovectomy with holmium-166 ferric hydroxide — a first experience
Journal of Nuclear Medicine · 2002 -
Strahlenexposition in der Umgebung von Patienten nach Gabe eines Radiopharmakons in der nuklearmedizinischen Diagnostik
Strahlenschutz · 2000 -
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy
Quarterly Journal of Nuclear Medicine · 2000 -
An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis
American Journal of Gastroenterology · 2000 -
111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung
Journal of Nuclear Medicine · 2001 -
Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region
Journal of the American College of Surgeons · 2003 -
Radiation doses deriving from patients treated with 166Ho-ferric hydroxide
Nuklearmedizin · 2003 -
Should lidocaine be avoided for local anesthesia in radiation synovectomy?
Quarterly Journal of Nuclear Medicine and Molecular Imaging · 2004 -
Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD
Nuclear Medicine Communications · 2004 -
13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels
Nuklearmedizin · 2006 -
Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism
Wiener Klinische Wochenschrift · 2008 -
Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine
Thyroid · 2012 -
Choroidal structural changes in airline pilots and cabin crew
International Ophthalmology · 2023 -
111In-DOTA-lanreotide (111In-MAURITIUS) scintigraphy in patients with lung tumors
Journal of Nuclear Medicine · 1999 -
Human biodistribution, safety and absorbed dose of 99mTc-P1666 vasoactive intestinal peptide (VIP) receptor scintigraphy
Journal of Nuclear Medicine · 1999 -
111In-DOTA-lanreotide (111In-MAURITIUS): a novel tracer for patients with lung tumors
European Journal of Nuclear Medicine · 1999 -
Comparative study of 111In-DOTA-lanreotide (LAN), 111In-DTPA-D-Phe-1-octreotide (OCT), 111In-DOTA-Tyr3-octreotide (TOCT) and F-18-PET in neuroendocrine tumor patients
European Journal of Nuclear Medicine · 1999 -
99mTc-P1666 vasoactive intestinal peptide (VIP) receptor scintigraphy: clinical efficacy, biodistribution and safety
European Journal of Nuclear Medicine · 1999 -
Comparative 111In-DOTA-lanreotide (LAN) and 111In-DOTA-Tyr3-octreotide (TOCT) scintigraphy: biodistribution and absorbed dose
European Journal of Nuclear Medicine · 1999 -
Experimental radiopeptide therapy (ERT) with 90Y-DOTA-Tyr3-DPhe1-octreotide
Journal of Nuclear Medicine · 2000 -
Experimental 90Y-DOTA-Tyr3-DPhe1-octreotide therapy in patients with metastatic tumor disease
European Journal of Nuclear Medicine · 2000 -
Syndrom X – Mechanismen der reduzierten koronaren Flussreserve
Nuklearmedizin (Austrian Society of Nuclear Medicine, 4th Congress, Vienna) · 2001 -
Prädiktive Parameter für eine reduzierte koronare Flussreserve bei Patienten mit Angina pectoris und blanden Koronarien
Nuklearmedizin (Austrian Society of Nuclear Medicine, 4th Congress, Vienna) · 2001 -
Myocardial vitality: NOGA Mapping im Vergleich mit FDG-PET und Tl-201
Nuklearmedizin (Austrian Society of Nuclear Medicine, 4th Congress, Vienna) · 2001 -
Mechanisms of a reduced coronary flow reserve in patients with angina and normal angiogram
2001 -
Incidence and mechanisms of a reduced coronary flow reserve in patients with angina and normal angiogram
2001 -
Impaired coronary vasoreactivity in subjects with subcli…